Norifumi Ueda

1.9k citations
62 papers · 1.6k indexed · h-index 23
Topics
Carcinogens and Genotoxicity Assessment (10 papers)Cancer-related Molecular Pathways (7 papers)Telomeres, Telomerase, and Senescence (5 papers)

In The Last Decade

Norifumi Ueda

58 papers receiving 1.5k citations

Peers

Norifumi Ueda
Comparison fields: 5 of 102
  • Molecular Biology 803
  • Oncology 245
  • Cancer Research 213
  • Cell Biology 197
  • Pathology and Forensic Medicine 188
Replace Reiko Makino with:
Reiko Makino Japan
Gang‐Hong Lee Japan
Takeshi Iwamura Japan
Wei Cui United States
Miki Shitashige Japan
Ken Brown United Kingdom
Anne R. Kinsella United Kingdom
Kazufumi Ohshiro United States
Yan Cui China
Carl E. Freter United States
Norifumi Ueda relative to Reiko Makino Japan Reiko Makino's profile →
Citations per field
00.5×4.3×
Reiko Makino · 1×
Citations per year

Countries citing papers authored by Norifumi Ueda

Since Specialization
Citations

This map shows the geographic impact of Norifumi Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norifumi Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norifumi Ueda more than expected).

Fields of papers citing papers by Norifumi Ueda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norifumi Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norifumi Ueda. The network helps show where Norifumi Ueda may publish in the future.

Co-authorship network of co-authors of Norifumi Ueda

This figure shows the co-authorship network connecting the top 25 collaborators of Norifumi Ueda. A scholar is included among the top collaborators of Norifumi Ueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norifumi Ueda. Norifumi Ueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 19
2 18
3 28
4 5
5 25
6 77
7 110
8 0
9 4
10 49
11 65
12 32
13 62
14 46
15 33
16 22
17 9
18 75
19 2
20 10

About Norifumi Ueda

Norifumi Ueda is a scholar working on Cancer Research, Cell Biology and Oncology, having authored 62 papers that have together received 1.6k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (10 papers), Cancer-related Molecular Pathways (7 papers) and Telomeres, Telomerase, and Senescence (5 papers). The work is most often cited by research in Cancer Research (213 citations), Cell Biology (197 citations) and Molecular Biology (803 citations). Norifumi Ueda has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Yasuhito Abe, Katsumi Kito, Suguru Matsumoto, Kazuhiro Shigemoto, Takashi Takeuchi, Taketoshi Sugiyama, Atsuro Sugita, Taketsugu Fujibuchi, Shinichi Murao and Tomoki Sumida. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026